Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as potential https://rajantwov068913.blog-gold.com/53520096/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide